Pliant Therapeutics, Inc. (PLRX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Pliant Therapeutics, Inc. (PLRX)
Company Performance

Current Price

as of Oct 16, 2024

$15.12

P/E Ratio

N/A

Market Cap

$919.32M

Description

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Metrics

Overview

  • HQSouth San Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerPLRX
  • Price$15.12+8.00%

Trading Information

  • Market Cap$919.32M
  • Float88.32%
  • Average Daily Volume (1m)427,595
  • Average Daily Volume (3m)416,711
  • EPS-$3.09

Company

  • RevenueN/A
  • Rev Growth (1yr)-100.00%
  • Net Income-$55.85M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$60.02M
  • EV$272.73M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B2.33